The Effect of Collagen Mediated Platelet Release on Plasma Prekallikrein Activation

Summary Collagen mediated platelet aggregation caused -5.6 ± 6.7% inhibition and +39.1 ± 15.2% potentiation of prekallikrein activation in plasma from normal healthy volunteers between 20–40 and 50–65 years of age, respectively (n = 15, p <0.01). The amouns of platelet factor-four (PF4) released in the two groups were not significantly different. Collagen treatment in the presence of indomethacin caused +11.5 ± 3.6% and +59.6 ± 19.5% potentiation in the 20–40 and 50–65 age groups respectively (p <0.02). Adrenaline mediated platelet aggregation caused -55.2 ± 7.1% and -35.2 ± 8.3% inhibition in the 20–40 and 50–65 age groups, respectively. Collagen treatment of platelet-deficient-plasma and platelet-rich-plasma in EDTA also caused potentiation of prekallikrein activation. The results indicate that the observed degree of prekallikrein activation after platelet aggregation is a net result of the inhibitory effect of PF4 and the potentiatory effect of activated platelets. The potentiatory effect was greater after collagen treatment as compared to adrenaline treatment, and in the 50–65 age group as compared to the 20–40 age group.

[1]  M. Scully,et al.  A platelet derived inhibitor of plasma prekallikrein activation. , 1983, Thrombosis research.

[2]  M. Scully,et al.  Inhibition Of Contact Activation By Platelet Factor 4 , 1980, Thrombosis and Haemostasis.

[3]  J. Griffin,et al.  Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. , 1981, Blood.

[4]  J. Griffin,et al.  Molecular assembly in the contact phase of the Hageman factor system. , 1979, The American journal of medicine.

[5]  M. Lesch,et al.  Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. , 1978, The Journal of laboratory and clinical medicine.

[6]  H. Weiss,et al.  Storage Pool Disease: Evidence for Clinical and Biochemical Heterogeneity , 1977, Thrombosis and Haemostasis.

[7]  H. Cohen,et al.  Purification and binding properties of human platelet factor four. , 1976, The Journal of biological chemistry.

[8]  H. Holmsen.  Biochemistry of the platelet release reaction. , 1975, Ciba Foundation symposium.

[9]  R. Farbiszewski,et al.  Release of Platelet Factor 4 in Vivo during Intravascular Coagulation and in Thrombotic States , 1968, Thrombosis and Haemostasis.

[10]  J. Hampton,et al.  Effect of Aggregating Agents on the Electrophoretic Mobility of Human Platelets , 1966, British medical journal.

[11]  J. Margolis.  THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.

[12]  W. Seegers,et al.  Differentiation of Certain Platelet Factors Related to Blood Coagulation , 1955, Circulation research.

[13]  H. Abramson.  THE ELECTROPHORESIS OF THE BLOOD PLATELETS OF THE HORSE WITH REFERENCE TO THEIR ORIGIN AND TO THROMBUS FORMATION , 1928, The Journal of experimental medicine.